Generics 16

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Fluocinolone manufacturers

16 products found

Filters

16 products found

fluocinolone + demeclocycline

Cream 1 % + 0.025 % - 30 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iran , Vietnam
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

fluocinolone + lidocaine

Suppositories 0.10 mg + 40 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Cyprus
Manufacturer #8921
A pharmaceutical manufacturer based in Europe that has been selling its products in Europe, Africa, North America, the Middle East, and CIS for 40+ years. The main therapeutic areas include oncology, allergology, and dermatology. Key production lines are Rx, medical devices, OTC, and nutraceuticals. The main dosage forms include oral solids, oral liquids, and injectables. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 3 days

fluocinolone + neomycin sulfate + polymyxin b sulfate

Ear drops 0.25 mg/ml + 3.5 mg/ml + 10000 IU/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply
Manufacturer #18444
A pharmaceutical manufacturer based in the EU that is selling its products for 100+ years. Key production lines are Rx, OTC, medical devices, nutraceuticals, and cosmetics. Main therapeutic areas include ophthalmology and dermatology.

Manufacturer usually replies in 2 days

fluocinolone + lidocaine

Cream 0.10 mg + 20 mg/g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Cyprus
Manufacturer #8921
A pharmaceutical manufacturer based in Europe that has been selling its products in Europe, Africa, North America, the Middle East, and CIS for 40+ years. The main therapeutic areas include oncology, allergology, and dermatology. Key production lines are Rx, medical devices, OTC, and nutraceuticals. The main dosage forms include oral solids, oral liquids, and injectables. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 3 days

fluocinolone

Cutaneous ointment 0.025%

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #3263

Manufacturer usually replies in 10 days

fluocinolone + neomycin

Cream 0.010 g + 0.350 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18782
The company has more than 40 years of experience. The company has a social conscience that generates health and well-being in people through reliable medicines based on the commitment of each of its members to quality and the use of cutting-edge technology. The company is committed to providing pharmaceutical products that meet customer expectations and national and international requirements; through solid processes of development, production, and distribution of the products, continuously improving the efficiency and effectiveness of the quality management system.

Manufacturer usually replies in 10 days

fluocinolone + neomycin sulfate

Cream 0.025% w/w + 0.5% w/w

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

fluocinolone

Cutaneous ointment 2.50 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19820

Manufacturer usually replies in 11 days

fluocinolone + lidocaine

Cutaneous gel 0.1mg/g+20mg/g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
WHO
Manufacturer #509
It is a MENA-wide leader in Pharmaceutical and consumer health products. It has a history of 40+ years. They have a long-established customer-centered approach to developing, producing, marketing, and commercializing high-quality affordable medicines and wellness consumer products in emerging markets, with more than 900 people serving patients in more than 40 countries throughout the Middle East, North Africa, and Europe.

Manufacturer usually replies in 10 days

fluocinolone + metronidazole + nystatin

Ovules Upon request

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18788
The company has offered a wide range of quality medicines for more than 50 years. Quality and honesty are the two focus areas for the company. The mission is to offer people reliable alternatives to pharmaceuticals that exceed quality standards. They deliver health benefits to society at a fair price.

Manufacturer usually replies in nan days

fluocinolone + neomycin sulfate

Cream 0.01g + 500 mg - 30 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18788
The company has offered a wide range of quality medicines for more than 50 years. Quality and honesty are the two focus areas for the company. The mission is to offer people reliable alternatives to pharmaceuticals that exceed quality standards. They deliver health benefits to society at a fair price.

Manufacturer usually replies in nan days

ciprofloxacin + fluocinolone

Ear drops 3mg/ml + 0.25mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Cetraxal Plus ®
Manufacturer #337
A pharmaceutical manufacturer based in the EU that has been active in 90+ countries selling its products in the EU, Africa, North America, Middle East, and Asia for 30+ years. Key production lines are Rx and OTC. Main therapeutic areas include diabetes, CNS, and dermatology. The company's production lines are GMP-compliant. The company possesses branches in the Middle East and Asia.

Manufacturer usually replies in 5 days

ciprofloxacin + fluocinolone

Vials 3 mg/ml + 0.25 mg/ml - 0.4 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #447
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, Africa, Middle East, North America, LATAM, and Asia for 60+ years. The company owns manufactories in Europe and NA that are GMP-compliant. Main therapeutic areas include gastroenterology, ophthalmology, and otolaryngology. The company has branches in Europe, North America, LATAM, and Africa.

Manufacturer usually replies in 25 days

miconazole + fluocinolone

Cream 2 %+0.025 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19219

Manufacturer usually replies in 6 days

ciprofloxacin + clotrimazole + fluocinolone

Cream 0.5 %+1 %+0.025 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19841

Manufacturer usually replies in 2 days

neomycin + miconazole + fluocinolone

Cream 0.5% + 2% + 0.01%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18271

Manufacturer usually replies in 4 days

Fluocinolone Manufacturers

Markets of interest

As a potent corticosteroid, Fluocinolone prevents the release of the substances in the body that cause inflammation. The medication is prescribed to treat such skin conditions as eczema, dermatitis, allergies, rash. The drug reduces the swelling, itching, and redness that can occur in these types of conditions. Fluocinolone is a medium-strength corticosteroid. The drug is available for sale in the form of as ointment at concentrations 0.25 milligram, 5 milligram or 3.3 milligram per gram, cream with different concentration of the medication, also suppositories at concentration 0.10, 40 milligram per gram, gel o.1, 0.20 milligram or 0,25 milligram per gram, eye drops, cutaneous solution, ear drops, rectal cream from manufacturers in various countries including Y. The drug is provided by a wide range of Fluocinolone suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Fluocinolone manufacturers and distributors are based in India.

Licensing and brand names

Fluocinolone under the trade name Otoken was approved by EMA in the European Union in 2014 for the treatment of dermatitis and eczema and in 2016 for the treatment of non-infectious uveitis. Under the trademark Synalar, Fluocinolone was approved by FDA in the USA in 2012. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Yutiq, Iluvien, Retisert, above mentioned Synalar, Dometic Oil, Flac, Derma-Smoothe/FS (Body Oil). One of the most popular branded versions of Fluocinolone is manufactured and supplied by the Indian pharmaceutical company Coral Drugs. Other manufacturing companies and distributors from the European Union, India, and Israel, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Fluocinolone as an active ingredient.

Target supply price

The wholesale acquisition cost of medication in the USA for Fluocinolone cream (15 gram) is around 29 USD. The retail price in the EU of this drug depending on the pack size ranges between 4 and 5 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Fluocinolone manufacturers and suppliers that you are looking for. You can also find the dossier status of Fluocinolone and the GMP approvals of the different variants of the medication. The product description of all Fluocinolone suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Fluocinolone is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Fluocinolone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.